Description
To enhance Canadian testing, contact tracing and data management/sharing for COVID-19 to manage the pandemic.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #12023-03-23$466,800
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2023-03-23 | $466,800 | — | To enhance Canadian testing, contact tracing and data management/sharing for COVID-19 to manage the pandemic. |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 106682214)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 115-2025-2026-Q4-18688 | Natural Resources Canada | Ressources naturelles Canada · The Canada Greener Homes Affordability Program | $11,530,000 | FY2026 |
| 276-2025-2026-Q4-00190 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Regional Innovation Ecosystem (RIE) | $130,000 | FY2026 |
| 115-2025-2026-Q4-18054 | Natural Resources Canada | Ressources naturelles Canada · Zero Emissions Vehicle Infrastructure Program | $400,000 | FY2026 |
| 271-2025-2026-Q1-00015 | Health Canada | Santé Canada · Climate Change and Health Capacity Building Program | $236,816 | FY2025 |
| 271-2025-2026-Q1-00038 | Health Canada | Santé Canada · Universal Access to Contraception and Diabetes Medications and Increased Access to Diabetes Devices and Supplies | $30,197,324 | FY2025 |
| 271-2024-2025-Q4-00118 | Health Canada | Santé Canada · National Strategy for Drugs for Rare Diseases Program | $10,303,059 | FY2025 |
Other recipients funded under "COVID-19 Safe Restart Agreements transfer payment program" by Health Canada | Santé Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 271-2022-2023-Q4-00221 | MANITOBA METIS FEDERATION INC. | FY2023 | $71,765 | FY2023 |
| 271-2022-2023-Q4-00223 | The Canadian Chamber of Commerce | FY2023 | $877,146 | FY2023 |
| 271-2022-2023-Q3-00038 | University of Saskatchewan | FY2023 | $244,476 | FY2023 |
| 271-2022-2023-Q2-00060 | OTTAWA HOSPITAL RESEARCH INSTITUTE/INSTITUT DE RECHERCHE DE L'HOPITAL D'OTTAWA | FY2023 | $502,009 | FY2023 |
| 271-2022-2023-Q2-00059 | Greater Toronto Airports Authority | FY2023 | $304,545 | FY2023 |
Cite as: Glassbox record view · Federal grants & contributions · 271-2022-2023-Q4-00219 · retrieved 2026-11-12.